Pernelle Lavaud

1.4k total citations
71 papers, 551 citations indexed

About

Pernelle Lavaud is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Pernelle Lavaud has authored 71 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 43 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in Pernelle Lavaud's work include Cancer Immunotherapy and Biomarkers (26 papers), Lung Cancer Treatments and Mutations (23 papers) and Lung Cancer Research Studies (16 papers). Pernelle Lavaud is often cited by papers focused on Cancer Immunotherapy and Biomarkers (26 papers), Lung Cancer Treatments and Mutations (23 papers) and Lung Cancer Research Studies (16 papers). Pernelle Lavaud collaborates with scholars based in France, Spain and Italy. Pernelle Lavaud's co-authors include Fabrice André, Yohann Loriot, Benjamin Besse, David Planchard, Charles Naltet, Laura Mezquita, Christophe Massard, Karim Fizazi, Giulia Baciarello and Anas Gazzah and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Pernelle Lavaud

66 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pernelle Lavaud France 12 377 290 94 82 78 71 551
Barbara Radecka Poland 12 448 1.2× 297 1.0× 115 1.2× 134 1.6× 51 0.7× 59 639
Noelia Vilariño Spain 12 417 1.1× 323 1.1× 98 1.0× 48 0.6× 74 0.9× 29 593
Yaobin Lin China 14 187 0.5× 231 0.8× 116 1.2× 87 1.1× 48 0.6× 50 460
Pooja Patel United States 7 228 0.6× 198 0.7× 121 1.3× 48 0.6× 53 0.7× 14 482
Takao Tsushima Japan 13 254 0.7× 282 1.0× 189 2.0× 62 0.8× 58 0.7× 44 628
Norikazu Matsuo Japan 14 442 1.2× 376 1.3× 95 1.0× 76 0.9× 153 2.0× 40 677
A. Spada Italy 9 227 0.6× 179 0.6× 95 1.0× 85 1.0× 83 1.1× 17 425
Coralie Moncharmont France 9 204 0.5× 160 0.6× 157 1.7× 83 1.0× 25 0.3× 26 437
Yalun Li China 12 164 0.4× 163 0.6× 117 1.2× 89 1.1× 82 1.1× 39 412
Diego Márquez-Medina Spain 10 308 0.8× 259 0.9× 102 1.1× 44 0.5× 48 0.6× 26 462

Countries citing papers authored by Pernelle Lavaud

Since Specialization
Citations

This map shows the geographic impact of Pernelle Lavaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pernelle Lavaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pernelle Lavaud more than expected).

Fields of papers citing papers by Pernelle Lavaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pernelle Lavaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pernelle Lavaud. The network helps show where Pernelle Lavaud may publish in the future.

Co-authorship network of co-authors of Pernelle Lavaud

This figure shows the co-authorship network connecting the top 25 collaborators of Pernelle Lavaud. A scholar is included among the top collaborators of Pernelle Lavaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pernelle Lavaud. Pernelle Lavaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leleu, Henri, Julia Bonastre, Caroline Caramella, et al.. (2025). Efficacy and cost-effectiveness of lung cancer screening in France with low-dose computed tomography. European Journal of Cancer Prevention. 35(3). 273–280.
2.
Guisier, Florian, Pernelle Lavaud, Laurent Greillier, et al.. (2024). Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN study. ESMO Open. 9(12). 103968–103968. 2 indexed citations
3.
Lavaud, Pernelle, Lodovica Zullo, Jarushka Naidoo, et al.. (2024). Early-Stage Non-Small Cell Lung Cancer: New Challenges with Immune Checkpoint Blockers and Targeted Therapies. Cancers. 16(16). 2779–2779. 9 indexed citations
4.
Parisi, Claudia, Damien Vasseur, Pernelle Lavaud, et al.. (2024). Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms. JTO Clinical and Research Reports. 6(3). 100773–100773.
5.
Tagliamento, Marco, Édouard Auclin, Mihaela Aldea, et al.. (2023). Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer. European Journal of Cancer. 182. 107–114. 25 indexed citations
6.
Auclin, Édouard, Anna Patrikidou, Laura Mezquita, et al.. (2023). Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma. Cancers. 15(4). 1066–1066. 10 indexed citations
7.
Ghigna, Maria‐Rosa, J. Remon Masip, Damien Vasseur, et al.. (2023). 1334P Activity of first line immunotherapy or chemo-immunotherapy in advanced NSCLC with SMARCA4 deficiency. Annals of Oncology. 34. S769–S769. 2 indexed citations
8.
Riudavets, Mariona, Damien Vasseur, Édouard Auclin, et al.. (2022). Clinical Utility and Outcomes Impact of Crystal Digital PCR of Sensitizing and Resistance EGFR Mutations in Patients With Advanced Non-Small Cell Lung Cancer. Clinical Lung Cancer. 23(6). e377–e383. 1 indexed citations
9.
10.
Oulhen, Marianne, Patrycja Pawlikowska, Genny Buson, et al.. (2021). Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors. npj Precision Oncology. 5(1). 67–67. 17 indexed citations
11.
Kfoury, Maria, Pernelle Lavaud, Aurélien Marabelle, et al.. (2021). Impact de l’utilisation de la corticothérapie systémique sur l’efficacité des inhibiteurs de points de contrôle immunitaire. Bulletin du Cancer. 108(6). 635–642. 1 indexed citations
12.
Aldea, Mihaela, Claudia Parisi, Luigi Cerbone, et al.. (2021). 1344P Molecular features of young cannabis smokers with advanced non-small cell lung cancer (aNSCLC). Annals of Oncology. 32. S1024–S1025. 3 indexed citations
13.
Epaillard, Nicolas, Yohann Loriot, Pernelle Lavaud, et al.. (2021). Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study. Frontiers in Oncology. 11. 9 indexed citations
14.
15.
Colomba, Émeline, Grégoire Marret, Giulia Baciarello, et al.. (2020). Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcome. European Journal of Cancer. 129. 117–122. 11 indexed citations
16.
Ferrara, Roberto, Francesco Facchinetti, Giuseppina Calareso, et al.. (2020). 1278P Hyperprogressive disease (HPD) upon first-line PD-1/PD-L1 inhibitors (ICI) as single agent or in combination with platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients (pts). Annals of Oncology. 31. S826–S826. 7 indexed citations
17.
Besse, Benjamin, Julien Adam, Nathalie Cozic, et al.. (2020). 1215O - SC Neoadjuvant atezolizumab (A) for resectable non-small cell lung cancer (NSCLC): Results from the phase II PRINCEPS trial. Annals of Oncology. 31. S794–S795. 74 indexed citations
18.
Aldea, Mihaela, Luigi Cerbone, Pernelle Lavaud, et al.. (2020). 638P Meningeal metastases (MM) in patients with metastatic castration resistant prostate cancer (mCRPC). Annals of Oncology. 31. S525–S525. 3 indexed citations
19.
Mezquita, Laura, Santiago Ponce Aix, Édouard Auclin, et al.. (2018). P3.12-11 Association of the Lung Immune Prognostic Index (LIPI) with Outcomes for Immune Checkpoint Inhibitors in Diffuse SCLC Patients. Journal of Thoracic Oncology. 13(10). S973–S974. 1 indexed citations
20.
Botticella, Angela, Toni Ibrahim, Laura Mezquita, et al.. (2018). P1.01-07 Immune-Related Pneumonitis in NSCLC Patients Treated with Immune Checkpoint Inhibitors (ICI): Impact of Previous Thoracic Radiotherapy. Journal of Thoracic Oncology. 13(10). S461–S462. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Radecka Breakdown of academic impact, for papers by Noelia Vilariño Breakdown of academic impact, for papers by Yaobin Lin Breakdown of academic impact, for papers by Pooja Patel Breakdown of academic impact, for papers by Takao Tsushima Breakdown of academic impact, for papers by Norikazu Matsuo Breakdown of academic impact, for papers by A. Spada Breakdown of academic impact, for papers by Coralie Moncharmont Breakdown of academic impact, for papers by Yalun Li Breakdown of academic impact, for papers by Diego Márquez-Medina
Rankless by CCL
2026